Physician profile
Ava Rose
NPI 1881968733
$437.45
in general payments reported to CMS, 2019-2025
7 companies · $13.50 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.00 · 2021: $29.19 · 2022: $67.14 · 2023: $22.89 · 2024: $245 · 2025: $13.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $264.81 | 2021-2024 | Eterna, Freestyle Libre 2 |
| Canon Medical Systems USA, INC. | $60.00 | 2019 | |
| Novo Nordisk INC | $36.11 | 2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $31.18 | 2022 | |
| Redhill Biopharma INC. | $17.56 | 2021 | |
| Astellas Pharma US INC | $14.29 | 2024 | Veozah |
| Exact Sciences Corporation | $13.50 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ava Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.